Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
‌

US Patent 7259149 Methods for treating or preventing angiogenesis-dependent symptoms

Patent 7259149 was granted and assigned to AnGes MG, Inc. on August, 2007 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributorsActivity

All edits

Edits on 1 Sep, 2023
"Add patent abstract"
Golden AI profile picture
Golden AI
edited on 1 Sep, 2023
Edits made to:
Article (+588 characters)
Article

Patent abstract

A method for enhancing the transfection efficiency of naked plasmid DNA in treating and/or preventing angiogenesis-dependent symptoms is provided by the present inventions. According to the present method, a suitable naked plasmid DNA is subjected for intramuscular injection under increased pressure inside the muscle or hyperbaric oxygen. Angiogenesis-dependent symptoms, including wounds, inflammatory diseases, critical limb ischemia, ischemia heart diseases, cerebral infarction, diabetic neuropathy, spinal canal stenosis, etc., may be treated by the present methods.

Edits on 14 Jul, 2023
"Remove leading 0 from patent number"
Golden AI profile picture
Golden AI
edited on 14 Jul, 2023
Edits made to:
Infobox (+1/-1 properties)
‌

US Patent 07259149 Methods for treating or preventing angiogenesis-dependent symptoms US Patent 7259149 Methods for treating or preventing angiogenesis-dependent symptoms

Infobox
Patent Number
0725914900
Patent Number
725914900
Edits on 23 May, 2023
"Remove website redirecting to Patent Public Search front page"
Golden AI profile picture
Golden AI
edited on 23 May, 2023
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
https://pdfpiw.uspto.gov/.piw?Docid=0725914900
Edits on 23 Apr, 2023
"Entity importer update"
Golden AI profile picture
Golden AI
edited on 23 Apr, 2023
Infobox
Is a
Patent
Patent
0
Current Assignee
‌
AnGes MG, Inc.
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
072591490
Date of Patent
August 21, 2007
0
Patent Application Number
105362740
Date Filed
December 2, 2003
0
Official Website
https://pdfpiw.uspto.gov/.piw?Docid=072591490
Patent Primary Examiner
‌
Anne M. Wehbe′
0
Edits on 28 Sep, 2022
"Entity importer update"
Golden AI profile picture
Golden AI
edited on 28 Sep, 2022
Infobox
Is a
Patent
Patent
0
Current Assignee
‌
AnGes MG, Inc.
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
072591490
Date of Patent
August 21, 2007
0
Patent Application Number
105362740
Date Filed
December 2, 2003
0
Official Website
https://pdfpiw.uspto.gov/.piw?Docid=072591490
Patent Primary Examiner
‌
Anne M. Wehbe′
0
Edits on 16 Jun, 2022
"Entity importer update"
Golden AI profile picture
Golden AI
edited on 16 Jun, 2022
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
https://pdfpiw.uspto.gov/.piw?Docid=07259149
Edits on 22 Nov, 2021
"Created via: Entity Importer"
Golden AI profile picture
Golden AI
created this topic on 22 Nov, 2021
Edits made to:
Infobox (+8 properties)
‌

 US Patent 07259149 Methods for treating or preventing angiogenesis-dependent symptoms

Infobox
Is a
Patent
Patent
Current assignee
‌
AnGes MG, Inc.
Patent jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
Patent number
07259149
Date of patent
August 21, 2007
Patent application number
10536274
Date Filed
December 2, 2003
Patent primary examiner
‌
Anne M. Wehbe′

Find more entities like US Patent 7259149 Methods for treating or preventing angiogenesis-dependent symptoms

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo
By using this site, you agree to our Terms of Service.